
AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
For Ubiquiti, being a shareholder really comes down to believing that its asset-light model and focused product lineup can keep converting sales into substantial profits and cash, while management returns a meaningful slice of that cash to investors. The latest quarter fits neatly into that story: higher sales and earnings, coupled with another US$0.80 dividend, reinforce the idea that the current payout is supported by recent performance rather than just board commentary. In the short term, the key catalysts remain execution on growth, margin resilience and any sign that the newly authorized US$500 million buyback is finally being used after several inactive tranches. On the risk side, the sharp pullback in the share price despite solid results hints that expectations, valuation sensitivity and governance questions are still front of mind for the market.
However, one governance issue in particular is worth a closer look for prospective investors. Ubiquiti's share price has been on the slide but might be dropping deeper into value territory. Find out whether it's a bargain at this price.Explore 11 other fair value estimates on Ubiquiti - why the stock might be worth over 2x more than the current price!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Every day counts. These free picks are already gaining attention. See them before the crowd does:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com